Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: A voxel-based morphometry study

Psychiatry Research - Neuroimaging

Volumn 154, Issue 3, 2007, Pages 275-279

  Potvin, Stéphane ^a,b   Mancini Marïe, Adham ^a,b   Fahim, Chérine ^a,b   Mensour, Boualem ^b   Lévesque, Johanne ^b   Karama, Sherif ^c   Beauregard, Mario ^b   Rompré, Pierre Paul ^a,b   Stip, Emmanuel ^a,b  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Schizophrenia; Substance use disorders; Voxel based morphometry

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; FEMALE; GRAY MATTER; HUMAN; MALE; MORPHOMETRICS; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 33947220415     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.11.009     Document Type: Article

References (30)

1. Ashburner J., and Friston K.J. Voxel-based morphometry-the methods. NeuroImage 11 (2000) 805-821
2. Bertolino A., Caforio G., Petruzzella V., Latorre V., Rubino V., Dimalta S., Torracco A., Blasi G., Quartesan R., Mattay V.S., Callicott J.H., Weinberger D.R., and Scarabino T. Prefrontal dysfunction in schizophrenia controlling for COMT Val(158)Met genotype and working memory performance. Psychiatry Research 147 (2006) 221-226
3. Boileau I., Assad J.M., Pihl R.O., Benkelfat C., Leyton M., Diksic M., Tremblay R.E., and Dagher A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49 (2003) 226-231
4. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arsenault L., Williams B., Braithwaite A., Poulton R., and Cragi I.W. Moderation of the effects of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biological Psychiatry 57 (2005) 1110-1127
5. Chambers R.A., and Taylor J.R. Animal modelling dual diagnosis schizophrenia: sensitization to cocaine in rats with neonatal ventral hippocampal lesions. Biological Psychiatry 56 (2004) 308-316
6. Drake R.E., Osher F.C., Noordsy D.L., Hurlbut S.C., Teague G.B., and Beaudett M.S. Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16 (1990) 57-67
7. Friston K.J., Ashburner J., Poline J.B., Frith C.D., Heather J.D., and Frackowiak R.S.J. Spatial registration and normalization of images. Human Brain Mapping 2 (1995) 165-189
8. Gardner E.L., and Vorel S.R. Cannabinoid transmission and reward-related events. Neurobiology of Disease 5 (1998) 502-533
9. Giuliani N.R., Calhoun V.D., Pearlson G.D., Francis A., and Buchanan R.W. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia. Schizophrenia Research 74 (2005) 135-147
10. Goldstein R.Z., and Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence of the involvement of the frontal cortex. American Journal of Psychiatry 159 (2002) 1642-1652
11. Ha T.H., Youn T., Ha K.S., Rho K.S., Lee J.M., Kim I.Y., Kim S.I., and Kwon J.S. Gray matter abnormalities in paranoid schizophrenia and their clinical correlates. Psychiatry Research Neuroimaging 132 (2004) 251-260
12. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., van Haren N.E., Koning H., Collins D.L., Evans A.C., and Kahn R.S. Focal gray matter density changes in schizophrenia. Archives of General Psychiatry 58 (2001) 1118-1125
13. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Reviews Neuroscience 2 (2001) 695-703
14. Joyal C.C., Pennanen C., Tiihonen E., Laakso M., Tiihonen J., and Aronen H.J. MRI volumetry of the vermis and the cerebellar hemispheres in men with schizophrenia. Psychiatry Research Neuroimaging 131 (2004) 115-124
15. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
16. Kubicki M., Shenton M.E., Salisbury D.F., Hirayasu Y., Kasai K., Kikinis R., Jolesz F.A., and McCarley R.W. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. NeuroImage 17 (2002) 1711-1719
17. Laruelle M., and Abi-Dargham A. Dopamine as the wind of psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology 13 (1999) 358-371
18. Massana G., Salgado-Pineda P., Junque C., Perez M., Baeza I., Pons A., Massana J., Navarro V., Blanch J., Morer A., Mercader J.M., and Bernardo M. Volume changes in gray matter in first-episode neuroleptic-naïve schizophrenic patients treated with risperidone. Journal of Clinical Psychopharmacology 25 (2005) 111-117
19. Mueser K.T., Drake R.E., and Wallach MA. Dual diagnosis: a review of etiological theories. Addictive Behaviors 23 (1998) 717-734
20. Neckelmann G., Specht K., Lund A., Ersland L., Smievoll A.I., Neckelmann D., and Hugdahl K. Mr morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations. International Journal of Neuroscience 116 (2006) 9-23
21. Rodriguez de Fonseca F., Del Arco I., Martin-Calderon J.L., Gorriti M.A., and Navarro M. Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiology of Disease 6 (1998) 483-501
22. Rutter M., Moffitt T.E., and Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. Journal of Child Psychology and Psychiatry 47 (2006) 226-261
23. Salgado-Pineda P., Junque C., Vendrell P., Baeza I., Bargallo N., Falcon C., and Bernardo M. Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. NeuroImage 21 (2004) 840-847
24. Seeman P. Atypical antipsychotics: mechanism of action. Canadian Journal of Psychiatry 47 (2002) 27-38
25. Sullivan E.V., and Pfefferbaum A. Neurocircuitry in alcoholism: a substrate of disruption and repair. Psychopharmacology 180 (2005) 583-594
26. Sullivan E.V., Deshmukh A., Desmond J.E., Mathalon D.H., Rosenbloom M.J., Lim K.O., and Pfefferbaum A. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Archives of General Psychiatry 57 (2000) 894-902
27. Sullivan E.V., Rosenbloom M.J., Serventi K.L., Desmukh A., and Pfefferbaum A. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. American Journal of Psychiatry 160 (2003) 1110-1116
28. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 36 (2002) 229-240
29. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64 (2003) 663-667
30. Wright I.C., McGuire P.K., Poline J.B., Travere J.M., Murray R.M., Frith C.D., Frackowiak R.S., and Friston K.J. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. NeuroImage 2 (1995) 244-252